U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07092605) titled 'Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures' on Dec. 18, 2024.
Brief Summary: The goal of this clinical study has two objectives. The Primary Objective is to evaluate the effectiveness of microdosed GLP-1 receptor agonists in improving measures of health, quality of life, and longevity. The Secondary Objective: To assess the impact of these therapies on weight management practices and metabolic health.
Study Start Date: Nov. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Longevity
Quality of Life
Mood
Inflammation
Immune Health
Pain Management
Weight Management
Alertness
Interv...